❮ Back to Researchers

Kamran Khan

MD, FRCPC, MPH

Scientist

Email: Kamran.Khan@unityhealth.to
Tel: 416-864-6060 Ext. 2976
Twitter: @HelloBlueDot

Research Programs

Labs

Kamran Khan Lab ❯

Biography

Dr. Kamran Khan is an infectious disease physician with training in public health and preventive medicine based at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital. He is a Professor of Medicine in the Division of Infectious Diseases and the Dalla Lana School Of Public Health at the University of Toronto. His research interests focus on the globalization of emerging and reemerging infectious diseases. He is also the founder of a social enterprise called BlueDot that develops innovative digital solutions to help governments, the private sector, and healthcare organizations build resilience to current and future global epidemic threats.

Recent Publications

  1. Colón-González, FJ, Gibb, R, Khan, K, Watts, A, Lowe, R, Brady, OJ et al.. Projecting the future incidence and burden of dengue in Southeast Asia. Nat Commun. 2023;14 (1):5439. doi: 10.1038/s41467-023-41017-y. PubMed PMID:37673859 PubMed Central PMC10482941.
  2. Tsui, JL, McCrone, JT, Lambert, B, Bajaj, S, Inward, RPD, Bosetti, P et al.. Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1. Science. 2023;381 (6655):336-343. doi: 10.1126/science.adg6605. PubMed PMID:37471538 .
  3. Tegally, H, Wilkinson, E, Tsui, JL, Moir, M, Martin, D, Brito, AF et al.. Dispersal patterns and influence of air travel during the global expansion of SARS-CoV-2 variants of concern. Cell. 2023;186 (15):3277-3290.e16. doi: 10.1016/j.cell.2023.06.001. PubMed PMID:37413988 PubMed Central PMC10247138.
  4. Gupta, S, Khan, K. Ten minutes with Doctor Kamran Khan. BMJ Lead. 2022; :. doi: 10.1136/leader-2022-000648. PubMed PMID:37200163 .
  5. Harish, V, Samson, TG, Diemert, L, Tuite, A, Mamdani, M, Khan, K et al.. Governing partnerships with technology companies as part of the COVID-19 response in Canada: A qualitative case study. PLOS Digit Health. 2022;1 (12):e0000164. doi: 10.1371/journal.pdig.0000164. PubMed PMID:36812643 PubMed Central PMC9931354.
  6. Olawoye, IB, Oluniyi, PE, Oguzie, JU, Uwanibe, JN, Kayode, TA, Olumade, TJ et al.. Emergence and spread of two SARS-CoV-2 variants of interest in Nigeria. Nat Commun. 2023;14 (1):811. doi: 10.1038/s41467-023-36449-5. PubMed PMID:36781860 PubMed Central PMC9924892.
  7. Huber, C, Watts, A, Thomas-Bachli, A, McIntyre, E, Tuite, A, Khan, K et al.. Using spatial and population mobility models to inform outbreak response approaches in the Ebola affected area, Democratic Republic of the Congo, 2018-2020. Spat Spatiotemporal Epidemiol. 2023;44 :100558. doi: 10.1016/j.sste.2022.100558. PubMed PMID:36707191 .
  8. Marwah, A, Ogoina, D, Au, NH, Gibb, NP, Portillo, MT, Thomas-Bachli, A et al.. Estimating the size of the monkeypox virus outbreak in Nigeria and implications for global control. J Travel Med. 2022;29 (8):. doi: 10.1093/jtm/taac149. PubMed PMID:36495194 .
  9. Tegally, H, Wilkinson, E, Martin, D, Moir, M, Brito, A, Giovanetti, M et al.. Global Expansion of SARS-CoV-2 Variants of Concern: Dispersal Patterns and Influence of Air Travel. medRxiv. 2022; :. doi: 10.1101/2022.11.22.22282629. PubMed PMID:36451885 PubMed Central PMC9709793.
  10. Tegally, H, Khan, K, Huber, C, de Oliveira, T, Kraemer, MUG. Shifts in global mobility dictate the synchrony of SARS-CoV-2 epidemic waves. J Travel Med. 2022;29 (8):. doi: 10.1093/jtm/taac134. PubMed PMID:36367200 PubMed Central PMC9793401.
Search PubMed

Affiliations & Other Activities

  • Staff Physician, Department of Medicine, Division of Infectious Diseases, St. Michael’s Hospital
  • Professor, Department of Medicine, Division of Infectious Diseases, Dalla Lana School Of Public Health, University of Toronto